Quantcast

DT MedTech gets FDA premarket approval for ankle replacement system

The U.S. Food and Drug Administration Wednesday granted premarket approval to Baltimore-based DT MedTech LLC for its Hintermann Series H3 Total Ankle Replacement System. The H3 is a three-piece, mobile-bearing implant for use as a non-cemented implant to replace a painful arthritic ankle joint because of primary osteoarthritis, post-traumatic osteoarthritis or arthritis secondary to inflammatory disease. The ...

To purchase a reprint of this article, contact reprints@thedailyrecord.com.

Leave a Reply

Your email address will not be published. Required fields are marked *

*